Ancora.ai: Germany Squamous Cell Head and Neck Cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Eligibility Criteria

Adults in Germany who have been diagnosed squamous cell head and neck cancer and their caregivers

Study Details

Patients are invited to participate in 120 minutes of activities on a secure online platform that can be completed at their own pace. Caregivers are invited to complete 45 minutes of a pre-task activity followed by a 60 minute online interview. The topic will be sharing experiences / discussing head and neck cancer.

Compensation

Participants will be compensated 150 EUR

Link to Sign up

https://www.surveymonkey.de/r/DE_KHK_Studie

Why sign up with Ancora.ai?   

Participating in research is an incredible way to share your personal opinions and insights to help improve cancer treatment and cancer patient experiences in the future. Your input will be used in anonymous form and you will be compensated for your time.

About Ancora.ai

At Ancora.ai we have built an award-winning, validated, free, unbiased, and secure platform where patients, caregivers and healthcare professionals can search for personalized cancer clinical trial and patient experience research options. Our vision is to democratize and diversify cancer research so the benefits of innovative medicine reach ALL patients, faster. Find out more and register at www.ancora.ai.